{"id":58456,"date":"2025-11-21T10:42:41","date_gmt":"2025-11-21T10:42:41","guid":{"rendered":"https:\/\/ibima.eu\/?page_id=58456"},"modified":"2025-11-21T10:54:14","modified_gmt":"2025-11-21T10:54:14","slug":"inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers","status":"publish","type":"page","link":"https:\/\/ibima.eu\/en\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/","title":{"rendered":"INTER-LOCAL &#8211; international call for better local treatment of rare and\/or hard to treat cancers"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1&#8243; custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/11\/inter-local-logo-1.png\u00bb title_text=\u00bbinter-local-logo (1)\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb54%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb23px|auto||auto|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbINTER-LOCAL &#8211; International call for clinical trials on development of local treatment  for rare and\/or hard-to-treat cancers \u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3&#8243; title_line_height=\u00bb1.3em\u00bb module_alignment=\u00bbcenter\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p style=\"text-align: justify;\">Cinco organizaciones europeas l\u00edderes en la lucha contra el c\u00e1ncer se han unido para impulsar la investigaci\u00f3n cl\u00ednica internacional centrada en tratamientos para c\u00e1nceres raros y\/o dif\u00edciles de tratar, lanzando una convocatoria de financiaci\u00f3n conjunta destinada a estimular la investigaci\u00f3n cl\u00ednica transfronteriza en esta \u00e1rea cr\u00edtica.<br data-start=\"515\" data-end=\"518\" data-is-only-node=\"\" \/>Se anima a los investigadores con base en <strong>Pa\u00edses Bajos, B\u00e9lgica, Espa\u00f1a, Noruega y Suecia<\/strong> a formar consorcios internacionales y presentar propuestas conjuntas. Tambi\u00e9n se puede solicitar un presupuesto limitado para incluir centros de otros pa\u00edses.<\/p>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbObjetivos de la convocatoria\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-start=\"0\" data-end=\"494\">El <strong data-start=\"3\" data-end=\"46\">objetivo principal de esta convocatoria<\/strong> es <strong data-start=\"50\" data-end=\"261\">estimular la investigaci\u00f3n cl\u00ednica internacional centrada en el desarrollo y optimizaci\u00f3n de tratamientos locales altamente efectivos (como cirug\u00eda o radioterapia) para c\u00e1nceres raros y\/o dif\u00edciles de tratar<\/strong>, con el fin de <strong data-start=\"277\" data-end=\"343\">mejorar la supervivencia y la calidad de vida de los pacientes<\/strong>, fomentar la colaboraci\u00f3n multic\u00e9ntrica internacional, y acelerar la generaci\u00f3n de evidencia que permita establecer gu\u00edas cl\u00ednicas basadas en datos.<\/p>\n<p data-start=\"496\" data-end=\"871\" data-is-last-node=\"\" data-is-only-node=\"\">En otras palabras, busca <strong data-start=\"521\" data-end=\"601\">cerrar la brecha de recursos y conocimientos en terapias locales innovadoras<\/strong>, donde el inter\u00e9s financiero de la industria farmac\u00e9utica es limitado, promoviendo consorcios internacionales que permitan acceder a suficientes pacientes para ensayos cl\u00ednicos de fase 2 y 3, y compartir experiencia especializada para avanzar en tratamientos efectivos.<\/p>\n<ul data-spread=\"false\" style=\"text-align: justify;\"><\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb10px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCriterios de la convocatoria\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb min_height=\u00bb88px\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li>\n<p data-start=\"63\" data-end=\"158\"><strong data-start=\"63\" data-end=\"81\">Tipo de c\u00e1ncer<\/strong>: El ensayo debe centrarse en un tipo de c\u00e1ncer raro y\/o dif\u00edcil de tratar, pudiendose abordar todas las etapas del c\u00e1ncer:<\/p>\n<ul data-start=\"161\" data-end=\"880\">\n<li data-start=\"161\" data-end=\"326\">\n<p data-start=\"163\" data-end=\"326\"><strong data-start=\"163\" data-end=\"181\">C\u00e1nceres raros<\/strong>: incidencia anual inferior a 6 casos por cada 100.000 personas en Europa, seg\u00fan los datos epidemiol\u00f3gicos o registros m\u00e1s recientes y fiables.<\/p>\n<\/li>\n<li data-start=\"329\" data-end=\"503\">\n<p data-start=\"331\" data-end=\"503\"><strong data-start=\"331\" data-end=\"363\">C\u00e1nceres dif\u00edciles de tratar<\/strong>: tasa de supervivencia a 5 a\u00f1os inferior al 25%, basada en evidencia cient\u00edfica revisada por pares publicada en revistas de alto impacto.<\/p>\n<\/li>\n<li data-start=\"506\" data-end=\"649\">\n<p data-start=\"508\" data-end=\"649\"><strong data-start=\"508\" data-end=\"532\">Subtipos moleculares<\/strong>: solo ser\u00e1n elegibles si la intervenci\u00f3n experimental requiere un enfoque terap\u00e9utico espec\u00edfico para ese subtipo.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p data-start=\"63\" data-end=\"158\"><strong data-start=\"63\" data-end=\"81\">Tipo de intervenci\u00f3n<\/strong>:<\/p>\n<ul data-start=\"161\" data-end=\"880\">\n<li data-start=\"161\" data-end=\"326\">\n<p data-start=\"163\" data-end=\"326\"><strong>Radioterapia.<\/strong><\/p>\n<\/li>\n<li data-start=\"329\" data-end=\"503\">\n<p data-start=\"331\" data-end=\"503\"><strong data-start=\"331\" data-end=\"363\">Intervenciones quir\u00fargicas<\/strong>.\u00a0<\/p>\n<\/li>\n<li data-start=\"329\" data-end=\"503\">\n<p data-start=\"331\" data-end=\"503\">La intervenci\u00f3n experimental <strong data-start=\"1183\" data-end=\"1263\">no debe involucrar el uso de f\u00e1rmacos, trazadores u otras sustancias activas<\/strong>. Ensayos con administraci\u00f3n local\/locorregional de f\u00e1rmacos no son elegibles.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"329\" data-end=\"503\">\n<p data-start=\"331\" data-end=\"503\"><strong data-start=\"1733\" data-end=\"1758\">Fase de investigaci\u00f3n<\/strong>: ensayos cl\u00ednicos de fase 2 y\/o 3, con preferencia por ensayos confirmatorios o pivotal.<\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li><strong>Pa\u00edses participantes<\/strong>: Pa\u00edses Bajos, Espa\u00f1a, Noruega, Suecia o B\u00e9lgica.<\/li>\n<li><strong>Tama\u00f1o del consorcio<\/strong>. Al menos 3 de los 5 pa\u00edses tienen que estar representado. Se fomenta la participaci\u00f3n de todos los pa\u00edses financiadores.<\/li>\n<li><strong data-start=\"3091\" data-end=\"3106\">Presupuesto<\/strong>: m\u00e1ximo 3 millones de euros por ensayo. Se puede solicitar hasta un 20% del presupuesto (m\u00e1x. 500.000 \u20ac) para centros en otros pa\u00edses europeos fuera de los financiadores, sujeto a disponibilidad.<\/li>\n<li style=\"list-style-type: none;\">\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li data-start=\"41\" data-end=\"99\">\n<p data-start=\"43\" data-end=\"99\"><strong data-start=\"43\" data-end=\"74\">Apertura de pre-propuestas:<\/strong> 1 de diciembre de 2025<\/p>\n<\/li>\n<li data-start=\"100\" data-end=\"191\"><strong data-start=\"102\" data-end=\"148\" style=\"font-size: 14px;\">Webinar para solicitantes:<\/strong><span style=\"font-size: 14px;\"> 9 de diciembre de 2025 (16:00-17:00 CET). Para registrarse hay que mandar un email a<a href=\"mailto:inter-local@kwf.nl\"> inter-local@kwf.nl<\/a>\u00a0<\/span><\/li>\n<li data-start=\"192\" data-end=\"245\">\n<p data-start=\"194\" data-end=\"245\"><strong data-start=\"194\" data-end=\"223\">Cierre de pre-propuestas:<\/strong> 22 de enero de 2026<\/p>\n<\/li>\n<li data-start=\"246\" data-end=\"315\">\n<p data-start=\"248\" data-end=\"315\"><strong data-start=\"248\" data-end=\"285\">Apertura de propuestas completas:<\/strong> principios de abril de 2026<\/p>\n<\/li>\n<li data-start=\"316\" data-end=\"375\">\n<p data-start=\"318\" data-end=\"375\"><strong data-start=\"318\" data-end=\"353\">Cierre de propuestas completas:<\/strong> por confirmar (TBA)<\/p>\n<\/li>\n<li data-start=\"376\" data-end=\"433\" data-is-last-node=\"\">\n<p data-start=\"378\" data-end=\"433\" data-is-last-node=\"\"><strong data-start=\"378\" data-end=\"407\">Decisi\u00f3n de financiaci\u00f3n:<\/strong> octubre\/noviembre de 2026<\/p>\n<\/li>\n<li style=\"list-style-type: none;\">\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb-23px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/jtc2026\/\">Web INTER-LOCAL\u00a0<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\"><a href=\"https:\/\/www.kwf.nl\/sites\/default\/files\/2025-09\/INTER-LOCAL-full-scope.pdf\">Texto Convocatoria<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/Logoblancofondoazul.jpg\u00bb title_text=\u00bbLogoblancofondoazul\u00bb force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb transform_scale_tablet=\u00bb202%|202%\u00bb transform_scale_phone=\u00bb202%|202%\u00bb transform_scale_last_edited=\u00bbon|tablet\u00bb transform_translate_tablet=\u00bb75px|25px\u00bb transform_translate_phone=\u00bb85px|-15px\u00bb transform_translate_last_edited=\u00bbon|phone\u00bb transform_translate_linked_tablet=\u00bboff\u00bb transform_rotate_tablet=\u00bb\u00bb transform_rotate_phone=\u00bb\u00bb transform_rotate_last_edited=\u00bbon|tablet\u00bb transform_skew_tablet=\u00bb\u00bb transform_skew_phone=\u00bb\u00bb transform_skew_last_edited=\u00bbon|tablet\u00bb transform_origin_tablet=\u00bb\u00bb transform_origin_phone=\u00bb\u00bb transform_origin_last_edited=\u00bbon|tablet\u00bb transform_styles_last_edited=\u00bbon|phone\u00bb min_height_tablet=\u00bb\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_margin_tablet=\u00bb||0px|-5px|false|false\u00bb custom_margin_phone=\u00bb||30px|-17px|false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb|200px|||false|false\u00bb custom_padding_tablet=\u00bb0px|200px|||false|false\u00bb custom_padding_phone=\u00bb|200px|||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb transform_styles_tablet=\u00bb\u00bb transform_styles_phone=\u00bb\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb14px|||-11%|false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p class=\"x_MsoNormal\" style=\"text-align: left;\"><span style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px; float: left;\" \/>Avenida Severo Ochoa, 35, 29590, M\u00e1laga<\/span><\/p>\n<p style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/phone.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>952 36 76 00<\/p>\n<p><a href=\"mailto:info@ibima.eu\" data-linkindex=\"0\" id=\"LPlnk315329\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/email.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>info@ibima.eu<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbAPARTADOS PRINCIPALES\u00bb menu_id=\u00bb1332&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.24.0&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb200px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbTEXTOS LEGALES\u00bb menu_id=\u00bb1333&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb-155px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin_tablet=\u00bb5px||||false|false\u00bb custom_margin_phone=\u00bb5px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow_network social_network=\u00bbtwitter\u00bb url=\u00bbhttps:\/\/x.com\/_ibima?lang=es%20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbfacebook\u00bb url=\u00bbhttps:\/\/www.facebook.com\/Ibima.eu\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b5998&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]facebook[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbinstagram\u00bb url=\u00bbhttps:\/\/www.instagram.com\/ibima_mlg\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#ea2c59&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]instagram[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/es.linkedin.com\/company\/ibima\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#007bb6&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbyoutube\u00bb url=\u00bbhttps:\/\/www.youtube.com\/channel\/UCY3UUZTi9X0ur-1Gd6MKonw\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#a82400&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]youtube[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbBuz\u00f3n de sugerencias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/comunicacion-con-el-instituto\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][dsm_icon_list_child text=\u00bbBuz\u00f3n de denuncias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/canal-de-denuncias\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbSuscr\u00edbete al Canal de Divulgaci\u00f3n\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/forms.gle\/5mczd4KKMqkBPdBy7&#8243; url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cinco organizaciones europeas l\u00edderes en la lucha contra el c\u00e1ncer se han unido para impulsar la investigaci\u00f3n cl\u00ednica internacional centrada en tratamientos para c\u00e1nceres raros y\/o dif\u00edciles de tratar, lanzando una convocatoria de financiaci\u00f3n conjunta destinada a estimular la investigaci\u00f3n cl\u00ednica transfronteriza en esta \u00e1rea cr\u00edtica.Se anima a los investigadores con base en Pa\u00edses Bajos, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-58456","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INTER-LOCAL - international call for better local treatment of rare and\/or hard to treat cancers - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INTER-LOCAL - international call for better local treatment of rare and\/or hard to treat cancers - Ibima\" \/>\n<meta property=\"og:description\" content=\"Cinco organizaciones europeas l\u00edderes en la lucha contra el c\u00e1ncer se han unido para impulsar la investigaci\u00f3n cl\u00ednica internacional centrada en tratamientos para c\u00e1nceres raros y\/o dif\u00edciles de tratar, lanzando una convocatoria de financiaci\u00f3n conjunta destinada a estimular la investigaci\u00f3n cl\u00ednica transfronteriza en esta \u00e1rea cr\u00edtica.Se anima a los investigadores con base en Pa\u00edses Bajos, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-21T10:54:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/\",\"name\":\"INTER-LOCAL - international call for better local treatment of rare and\\\/or hard to treat cancers - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"datePublished\":\"2025-11-21T10:42:41+00:00\",\"dateModified\":\"2025-11-21T10:54:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INTER-LOCAL &#8211; international call for better local treatment of rare and\\\/or hard to treat cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INTER-LOCAL - international call for better local treatment of rare and\/or hard to treat cancers - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/","og_locale":"en_GB","og_type":"article","og_title":"INTER-LOCAL - international call for better local treatment of rare and\/or hard to treat cancers - Ibima","og_description":"Cinco organizaciones europeas l\u00edderes en la lucha contra el c\u00e1ncer se han unido para impulsar la investigaci\u00f3n cl\u00ednica internacional centrada en tratamientos para c\u00e1nceres raros y\/o dif\u00edciles de tratar, lanzando una convocatoria de financiaci\u00f3n conjunta destinada a estimular la investigaci\u00f3n cl\u00ednica transfronteriza en esta \u00e1rea cr\u00edtica.Se anima a los investigadores con base en Pa\u00edses Bajos, [&hellip;]","og_url":"https:\/\/ibima.eu\/en\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/","og_site_name":"Ibima","article_modified_time":"2025-11-21T10:54:14+00:00","og_image":[{"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/","url":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/","name":"INTER-LOCAL - international call for better local treatment of rare and\/or hard to treat cancers - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","datePublished":"2025-11-21T10:42:41+00:00","dateModified":"2025-11-21T10:54:14+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/es\/inter-local-international-call-for-better-local-treatment-of-rare-and-or-hard-to-treat-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"INTER-LOCAL &#8211; international call for better local treatment of rare and\/or hard to treat cancers"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/58456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=58456"}],"version-history":[{"count":4,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/58456\/revisions"}],"predecessor-version":[{"id":58462,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/58456\/revisions\/58462"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=58456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}